Skip to main content

Advertisement

Log in

Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Objectives

This study investigated a large cohort of patients to construct a predictive nomogram and a web-based survival rate calculator for dynamically predicting the cancer-specific survival of patients with primary hypopharyngeal squamous cell carcinoma (HSCC).

Methods

Patients (n = 2007) initially diagnosed with primary HSCC from 2004 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. All patients were randomly divided into the training and validation cohorts (1:1). The Lasso Cox regression model was applied to identify independent risk factors of cancer-specific survival for a predictive nomogram and a web-based calculator. The model was evaluated by concordance index, calibration, and decision curve analysis.

Results

Cancer-specific survival rates decreased with time, while 3-year conditional survival increased. Cancer-specific deaths evolved from relatively high within the first 3 years to low thereafter. Age, race, T stage, N stage, M stage, surgery, radiotherapy, chemotherapy, and marital status were identified as independent risk factors. We constructed a predictive nomogram for survival and a web-based calculator (https://linzhongyang.shinyapps.io/Hypopharyngeal/). Additionally, a prognostic risk stratification was developed according to nomogram total points.

Conclusions

Patients with primary HSCC were found at a high risk of cancer-specific death during the first 3 years, indicating that additional effective follow-up strategies should be implemented over the period. This is the first study to construct a predictive nomogram and a web-based calculator for all patients with HSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30

    Article  Google Scholar 

  2. Hall SF, Groome PA, Irish J et al (2008) The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 118(8):1362–1371

    Article  Google Scholar 

  3. Hoffman HT, Karnell LH, Shah JP et al (1997) Hypopharyngeal cancer patient care evaluation. Laryngoscope 107(8):1005–1017

    Article  CAS  Google Scholar 

  4. Colevas AD, Yom SS, Pfister DG et al (2018) NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Cancer Netw 16(5):479–490

    Article  Google Scholar 

  5. Henson DE, Schwartz AM, Chen D et al (2014) The clinical implications of integrating additional prognostic factors into the TNM. J Surg Oncol 109(5):391–394

    Article  Google Scholar 

  6. Heng Y, Zhu X, Zhou L et al (2020) A prognostic nomogram for predicting the long-term survival outcome of hypopharyngeal squamous cell carcinoma patients after tumour resection to assist the decision-making of postoperative adjuvant treatment. Eur J Surg Oncol 46(2):245–251

    Article  Google Scholar 

  7. Arends CR, Petersen JF, van der Noort V et al (2019) Optimizing survival predictions of hypopharynx cancer: development of a clinical prediction model. The Laryngoscope. https://doi.org/10.1002/lary.28345[published online ahead of print November 6 2019]

    Article  PubMed  Google Scholar 

  8. Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385–395

    Article  CAS  Google Scholar 

  9. Camp RL, Dolled-Filhart M, Rimm DL (2004) X-Tile. A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259

    Article  CAS  Google Scholar 

  10. Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594

    Article  Google Scholar 

  11. Kent DM, Steyerberg E, van Klaveren D (2018) Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ (Clin Res ed) 363:k4245

    Article  Google Scholar 

  12. Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26(8):1364–1370

    Article  Google Scholar 

  13. Balachandran VP, Gonen M, Smith JJ et al (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173–e180

    Article  Google Scholar 

  14. Necchi A, Sonpavde G, Vullo SL et al (2017) Nomogram-based prediction of overall survival in patients with metastatic urothelial carcinoma receiving first-line platinum-based chemotherapy: retrospective international study of invasive/advanced cancer of the urothelium (RISC). Eur Urol 71(2):281–289

    Article  CAS  Google Scholar 

  15. Kim JH, Kim HS, Seo W et al (2011) External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer. Ann Oncol 23(2):361–367

    Article  Google Scholar 

  16. Pan JJ, Ng WT, Zong JF et al (2016) Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(21):3307–3315

    Article  CAS  Google Scholar 

  17. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17(6):1471–1474

    Article  Google Scholar 

  18. Sharp L, McDevitt J, Carsin AE et al (2014) Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study. Cancer Epidemiol Biomarkers Prev 23(11):2579–2590

    Article  CAS  Google Scholar 

  19. Ness-Jensen E, Gottlieb-Vedi E, Wahlin K et al (2018) All-cause and cancer-specific mortality in GORD in a population-based cohort study (the HUNT study). Gut 67(2):209–215

    Article  Google Scholar 

  20. Swords DS, Mulvihill SJ, Firpo MA et al (2018) Causes of death and conditional survival estimates of medium- and long-term survivors of pancreatic adenocarcinoma. JAMA Oncol 4(8):1129–1130

    Article  Google Scholar 

  21. Margonis GA, Buettner S, Andreatos N et al (2019) Prognostic factors change over time after hepatectomy for colorectal liver metastases: a multi-institutional, international analysis of 1099 patients. Ann Surg 269(6):1129–1137

    Article  Google Scholar 

  22. Newman JR, Connolly TM, Illing EA et al (2015) Survival trends in Hypopharyngeal cancer: a population-based review. The Laryngoscope 125(3):624–629

    Article  Google Scholar 

  23. Tulunay-Ugur OE, McClinton C, Young Z et al (2013) Functional outcomes of chemoradiation in patients with head and neck cancer. Otolaryngol Head Neck Surg 148(1):64–68

    Article  Google Scholar 

  24. Lefebvre JL, Pointreau Y, Rolland F et al (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31(7):853–859

    Article  CAS  Google Scholar 

  25. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 88(13):890–899

    Article  CAS  Google Scholar 

  26. Machtay M, Moughan J, Farach A et al (2012) Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys 84(4):983–989

    Article  Google Scholar 

  27. Tassler AB, Gooding WE, Ferris RL (2019) Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit? Head Neck 41(7):2167–2173

    Article  Google Scholar 

  28. Hochfelder CG, McGinn AP, Mehta V et al (2019) Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: a surveillance, epidemiology, and end results-based study. The Laryngoscope. https://doi.org/10.1002/lary.28452[published online ahead of print December 10 2019]

    Article  PubMed  Google Scholar 

  29. Harris BN, Biron VL, Donald P et al (2015) Primary surgery vs chemoradiation treatment of advanced-stage hypopharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 141(7):636–640

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank all the medical staff who contributed to the maintenance of the medical record database.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chang Lin.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 90 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Z., Lin, H. & Lin, C. Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma. Int J Clin Oncol 25, 1260–1269 (2020). https://doi.org/10.1007/s10147-020-01671-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-020-01671-4

Keywords

Navigation